TRUE Private Wealth Advisors Sells 3,177 Shares of The Clorox Company (NYSE:CLX)

TRUE Private Wealth Advisors lowered its stake in shares of The Clorox Company (NYSE:CLX - Free Report) by 70.7% in the third quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 1,316 shares of the company's stock after selling 3,177 shares during the quarter. TRUE Private Wealth Advisors' holdings in Clorox were worth $214,000 at the end of the most recent reporting period.

Other hedge funds and other institutional investors have also added to or reduced their stakes in the company. Catalyst Capital Advisors LLC purchased a new position in Clorox in the third quarter valued at about $54,000. Raymond James & Associates grew its position in shares of Clorox by 32.8% in the 2nd quarter. Raymond James & Associates now owns 267,632 shares of the company's stock valued at $36,524,000 after acquiring an additional 66,149 shares during the period. M&G Plc bought a new stake in shares of Clorox during the 2nd quarter worth about $876,000. Cetera Investment Advisers raised its position in shares of Clorox by 140.6% in the 1st quarter. Cetera Investment Advisers now owns 74,032 shares of the company's stock valued at $11,335,000 after buying an additional 43,265 shares in the last quarter. Finally, AQR Capital Management LLC increased its position in Clorox by 8.6% during the 2nd quarter. AQR Capital Management LLC now owns 287,277 shares of the company's stock worth $39,121,000 after purchasing an additional 22,676 shares in the last quarter. Institutional investors and hedge funds own 78.53% of the company's stock.

Insider Activity at Clorox

In other news, EVP Angela C. Hilt sold 1,733 shares of the stock in a transaction that occurred on Friday, September 6th. The stock was sold at an average price of $165.52, for a total transaction of $286,846.16. Following the completion of the transaction, the executive vice president now directly owns 13,471 shares in the company, valued at approximately $2,229,719.92. This represents a 11.40 % decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website. 0.57% of the stock is currently owned by corporate insiders.

Wall Street Analyst Weigh In

Several brokerages recently issued reports on CLX. Jefferies Financial Group raised shares of Clorox from a "hold" rating to a "buy" rating and increased their target price for the stock from $174.00 to $187.00 in a research note on Tuesday, October 1st. JPMorgan Chase & Co. increased their target price on shares of Clorox from $148.00 to $174.00 and gave the stock a "neutral" rating in a research report on Friday, October 11th. Citigroup raised their price objective on shares of Clorox from $165.00 to $170.00 and gave the company a "neutral" rating in a research report on Friday, September 6th. Evercore ISI lowered their target price on shares of Clorox from $140.00 to $139.00 and set an "underperform" rating on the stock in a research note on Monday, October 14th. Finally, TD Cowen raised shares of Clorox from a "sell" rating to a "hold" rating and raised their target price for the company from $155.00 to $170.00 in a research note on Wednesday, November 6th. Five analysts have rated the stock with a sell rating, ten have given a hold rating and one has given a buy rating to the stock. According to data from MarketBeat.com, Clorox currently has an average rating of "Hold" and a consensus target price of $155.00.

Clorox Stock Up 0.0 %

Shares of CLX traded up $0.02 during trading hours on Friday, hitting $167.17. The company had a trading volume of 465,385 shares, compared to its average volume of 1,220,052. The firm has a fifty day moving average price of $163.09 and a 200-day moving average price of $149.47. The company has a debt-to-equity ratio of 11.08, a quick ratio of 0.62 and a current ratio of 1.00. The stock has a market capitalization of $20.69 billion, a price-to-earnings ratio of 58.25, a P/E/G ratio of 3.09 and a beta of 0.41. The Clorox Company has a 52-week low of $127.60 and a 52-week high of $171.35.

Clorox (NYSE:CLX - Get Free Report) last issued its earnings results on Wednesday, October 30th. The company reported $1.86 earnings per share for the quarter, topping analysts' consensus estimates of $1.36 by $0.50. Clorox had a return on equity of 316.08% and a net margin of 4.78%. The business had revenue of $1.76 billion during the quarter, compared to analyst estimates of $1.64 billion. During the same quarter in the previous year, the firm earned $0.49 EPS. Clorox's revenue was up 27.0% on a year-over-year basis. On average, equities research analysts forecast that The Clorox Company will post 6.85 EPS for the current fiscal year.

Clorox Announces Dividend

The business also recently disclosed a quarterly dividend, which will be paid on Friday, February 14th. Investors of record on Wednesday, January 29th will be paid a dividend of $1.22 per share. The ex-dividend date of this dividend is Wednesday, January 29th. This represents a $4.88 dividend on an annualized basis and a dividend yield of 2.92%. Clorox's dividend payout ratio (DPR) is presently 170.04%.

Clorox Company Profile

The Clorox Company manufactures and markets consumer and professional products worldwide. It operates through four segments: Health and Wellness, Household, Lifestyle, and International. The Health and Wellness segment offers cleaning products, such as laundry additives and home care products primarily under the Clorox, Clorox2, Scentiva, Pine-Sol, Liquid-Plumr, Tilex, and Formula 409 brands; professional cleaning and disinfecting products under the CloroxPro and Clorox Healthcare brands; professional food service products under the Hidden Valley brand; and vitamins, minerals and supplement products under the RenewLife, Natural Vitality, NeoCell, and Rainbow Light brands in the United States.